⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SGMO News
Sangamo Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
SGMOQ
SGMO
PTC
Global RNAi Technology Market is Expected to Showcase Significant Growth at a CAGR of ~14% by 2034 | DelveInsight
globenewswire.com
BNTX
MRNA
DVAX
ALNY
BIIB
IONS
ARCT
VRTX
PFE
SGMO
AZN
CAT
TMO
LH
Form 8-K
sec.gov
SGMOQ
SGMO
PTC
LLY
Form 8-K
sec.gov
SGMOQ
SGMO
RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry
prnewswire.com
BIIB
REGN
GILD
BTE
BROS
BFLY
BCTX
BCRX
BTAI
ALRS
CAPR
CRIS
CYCN
EXAS
FATE
GNTX
HRMY
INCY
IONS
KODK
LAKE
LULU
MRNA
NBIX
NTRA
OCGN
ORGN
PGEN
PLRX
RARE
RGNX
RXRX
SAVA
SGMO
SNOW
SRPT
STEM
TGTX
TLSA
TXG
VRTX
ZETA
Form 8-K
sec.gov
SGMOQ
SGMO
Form 8-K
sec.gov
SGMOQ
SGMO
Form 8-K/A
sec.gov
SGMO
Form 8-K
sec.gov
SGMO
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
globenewswire.com
SGMO
LLY
AMPH